
Transactions: Healthcare
Filter


Directed new share issue in Clavis Pharma ASA (NO) — NOK 163 million


Public bid and acquisition by Baxter Inc (US) of Althin Medical (SE) — SEK 1.1 billion
Initial public offering of Bavarian Nordic Research Institute A/S (DK) — DKK 195 million


Merger of Axis Biochemicals ASA (NO) and Shield Diagnostics (UK) — NOK 970 million


Divestment of SBL Vaccin (SE) by the Swedish Government (SE) — SEK 345 million


Divestment and equity financing of Biovitrum AB (SE) — SEK 1.6 billion


Pharmacia (US) / Monsanto (US) — Spin-off — USD 3.7 billion

Divestment of Maersk Medical (DK) to Nordic Capital (SE) by A.P. Møller (DK) — Amount not disclosed.

Divestment of Pharmadule Emtunga (SE) to 3i (UK) by Industrial Development & Investment AB ("IDI") (SE) — Amount not disclosed.


Public offering for Pharmacia (US) by Pfizer (US) — USD 57 billion
- Föregående
- 1
- …
- 27
- 28